Results 171 to 180 of about 1,090,190 (299)
'All In': Equitable Health Outcomes Require Culturally Safe Care for Everybody. [PDF]
Filoche S +7 more
europepmc +1 more source
‘Shelter is a Dignity’: Rental Racism, Stress and Housing (In)justice
ABSTRACT Australia's private rental sector is in crisis, and culturally and racially minoritised renters face compounded harms through both covert and everyday direct forms of rental racism. Drawing on five community‐based focus groups in Melbourne (n = 37), the paper explores how racism manifests across the rental pathway and how it structures the ...
Erika Martino +3 more
wiley +1 more source
Tracking mental health and cognitive changes following the Australian social media minimum age legislation: a 4-wave longitudinal study protocol. [PDF]
Bilston A +8 more
europepmc +1 more source
In multiple sclerosis (MS), anti‐CD20 therapies have been associated with increased infection risk, but whether this risk differs between rituximab and ocrelizumab is not known. Using a nationwide cohort, we studied infection risk and relapse outcomes among 16,872 treatment episodes with rituximab, ocrelizumab, or other disease‐modifying therapies ...
Thomas Frisell +2 more
wiley +1 more source
Changing contexts of death and dying: Influence of the COVID-19 pandemic and voluntary assisted dying legislation on death literacy in Australia. [PDF]
Shrestha S, Grindrod A, Lee S, Noonan K.
europepmc +1 more source
Intensive or organic farming systems may expose pigs to management or environmental challenges. Our preliminary results concluded that organic farming might enhance adaptive immune function, showing that improvements in welfare can translate into measurable immunological benefits, based on the correlation between welfare assessment and physiological ...
Dorotea Ippolito +15 more
wiley +1 more source
A comparative analysis of smoke-free regulations in 23 Chinese cities, 2015-2022. [PDF]
Chen Y +9 more
europepmc +1 more source
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis +22 more
wiley +1 more source

